Holen Sie sich die Stockscreener-App
35.32
1.67%
0.58
Schlusskurs vom Vortag:
$34.74
Offen:
$35.21
24-Stunden-Volumen:
851.96K
Relative Volume:
0.54
Marktkapitalisierung:
$2.16B
Einnahmen:
$362.27M
Nettoeinkommen (Verlust:
$-85.19M
KGV:
-24.36
EPS:
-1.45
Netto-Cashflow:
$-68.71M
1W Leistung:
+9.05%
1M Leistung:
+11.84%
6M Leistung:
-9.71%
1J Leistung:
-21.72%
1-Tages-Spanne:
$34.86
$35.79
1-Wochen-Bereich:
$32.53
$37.73
52-Wochen-Spanne:
$23.30
$55.33
Twist Bioscience Corp Stock (TWST) Company Profile
Firmenname
Twist Bioscience Corp
Sektor
Branche
Telefon
800-719-0671
Adresse
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Vergleichen Sie TWST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
35.32 | 2.13B | 362.27M | -85.19M | -68.71M | -1.45 |
|
TMO
Thermo Fisher Scientific Inc
|
618.86 | 227.87B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
238.37 | 165.99B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
713.35 | 56.89B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
148.52 | 41.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
242.41 | 41.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-04 | Eingeleitet | Stephens | Overweight |
| 2024-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2024-06-04 | Eingeleitet | Guggenheim | Buy |
| 2024-01-17 | Hochstufung | Goldman | Neutral → Buy |
| 2023-09-27 | Eingeleitet | Berenberg | Buy |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-29 | Eingeleitet | William Blair | Outperform |
| 2021-06-04 | Eingeleitet | Goldman | Neutral |
| 2021-04-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-02-05 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-10-20 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2019-05-31 | Eingeleitet | Evercore ISI | Outperform |
| 2018-11-26 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Twist Bioscience Corp Aktie (TWST) Neueste Nachrichten
Twist Bioscience (TWST) Valuation Check After TD Cowen Buy Rating And Raised Outlook - Yahoo! Finance Canada
Analyst Brendan Smith Maintains "Buy" on Twist Bioscience (TWST), Raises Price Target | TWST Stock News - GuruFocus
Twist Bioscience Corp ($TWST) CEO and COB 2025 Pay Revealed - Quiver Quantitative
Form ARS Twist Bioscience Corp For: Sep 30 - StreetInsider
Twist Bioscience (NASDAQ:TWST) Trading 7.4% HigherShould You Buy? - MarketBeat
Twist Bioscience Corporation (TWST) Stock Analysis: Unpacking a 10.29% Potential Upside in the Diagnostics & Research Sector - DirectorsTalk Interviews
Cathie Wood’s ARK buys Beam and Twist Bioscience stocks, sells Roku - Investing.com India
Barclays Keeps Its Overweight Rating On Twist Bioscience Corporation (TWST) - Insider Monkey
Cathie Wood’s ARK makes strategic stock moves, buys Intellia and sells Roku - Investing.com
Twist Bioscience2025 Funding Rounds & List of Investors - Tracxn
Insider Selling: Twist Bioscience (NASDAQ:TWST) CEO Sells 1,605 Shares of Stock - MarketBeat
Twist Bioscience (NASDAQ:TWST) Stock Price Down 4.1%Time to Sell? - MarketBeat
New Product Launch Strengthens Bull Case for Twist Bioscience ( TWST) - Finviz
Twist Bioscience (TWST) Stock News Today: Forecasts, Analyst Targets, and Key Catalysts (Dec. 22, 2025) - ts2.tech
What valuation multiples suggest for Twist Bioscience Corporation stock2025 Price Targets & Low Risk High Reward Trade Ideas - Улправда
Will Twist Bioscience Corporation (0ME) stock remain on Wall Street radarTrade Ideas & Verified Swing Trading Watchlist - Улправда
Is Twist Bioscience Corporation (0ME) stock a contrarian opportunityPortfolio Growth Summary & Weekly Chart Analysis and Guides - DonanımHaber
Published on: 2025-12-18 20:43:14 - Улправда
Twist Bioscience (TWST): Evaluating Valuation After New Research‑Grade Plasmid DNA Preps Launch - simplywall.st
Twist Bioscience to Present at J.P. Morgan 2026 Healthcare Conference - Business Wire
Squarepoint Ops LLC Raises Stock Position in Twist Bioscience Corporation $TWST - MarketBeat
Twist Bioscience (NASDAQ:TWST) Trading Up 6.4%Should You Buy? - MarketBeat
Twist Bioscience (TWST) Stock News Today: Latest Catalysts, Analyst Forecasts, and 2026 Outlook (Dec. 17, 2025) - ts2.tech
Twist Bioscience Corporation (TWST) Stock Analysis: Exploring a Potential 15% Upside for Forward-Thinking Investors - DirectorsTalk Interviews
Aptamer Group Signs First Licensing Deal With Twist Bioscience - DirectorsTalk Interviews
Aptamer Group PLCLicensing agreement with Twist Bioscience - Research Tree
Aptamer Group signs licensing deal with Twist Bioscience for NGS market - Investing.com Canada
Barclays Raises Price Target for Twist Bioscience (TWST) to $39 - GuruFocus
Barclays Raises Price Target for Twist Bioscience (TWST) to $39 | TWST Stock News - GuruFocus
Is Twist’s New High‑Quality Plasmid DNA Preps Business Altering The Investment Case For Twist Bioscience (TWST)? - simplywall.st
Nikko Asset Management Americas Inc. Sells 116,361 Shares of Twist Bioscience Corporation $TWST - MarketBeat
Twist Bioscience Corporation $TWST Stock Holdings Lifted by EdgePoint Investment Group Inc. - MarketBeat
Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
DNA Computing Market - GlobeNewswire Inc.
Multiple Headwinds Hit Twist BioScience Corp. (TWST) in Q3 - MSN
VP Green Surrenders 877 Of Twist Bioscience Corp [TWST] - TradingView — Track All Markets
VP Green Files To Sell 877 Of Twist Bioscience Corp [TWST] - TradingView — Track All Markets
VP Cho Files To Sell 398 Of Twist Bioscience Corp [TWST] - TradingView — Track All Markets
Twist Bioscience (TWST): Valuation Check After New Research-Grade Plasmid DNA Preps Boost Investor Interest - Yahoo Finance
How Twist’s New Preclinical-Grade Plasmid DNA Preps Could Reshape the TWST Nucleic Acid Therapeutics Story - Yahoo Finance
Is Twist’s New Endotoxin‑Controlled Plasmid DNA Offering Altering The Investment Case For TWST? - simplywall.st
Twist Bioscience Corp. Hits New 52-Week Low at $23.50 - Markets Mojo
Twist Bioscience Introduces New Plasmid DNA Preparation Products - marketscreener.com
Can Twist Bioscience Corporation (0ME) stock survive global slowdown2025 Risk Factors & Free Safe Entry Trade Signal Reports - Newser
Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research - Business Wire
How analysts revise price targets for Twist Bioscience Corporation (0ME) stockStock Surge & Safe Swing Trade Setups - Newser
Virtus Advisers LLC Cuts Stock Position in Twist Bioscience Corporation $TWST - MarketBeat
Cell Culture Microcarriers Market Size Leads at 8.54% CAGR by 2034 – Towards Healthcare - GlobeNewswire Inc.
A 'renter’s market' allowed this CEO to bring everyone together for lessSan Francisco Business Times - The Business Journals
Franklin Resources Inc. Decreases Stock Holdings in Twist Bioscience Corporation $TWST - MarketBeat
Twist Bioscience Corporation $TWST Stake Raised by XTX Topco Ltd - MarketBeat
Finanzdaten der Twist Bioscience Corp-Aktie (TWST)
Umsatz
Nettogewinn
Free Cashflow
ENV
Twist Bioscience Corp-Aktie (TWST) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Green Paula | SVP of Human Resources |
Dec 22 '25 |
Sale |
34.56 |
273 |
9,434 |
166,639 |
| Cho Dennis | See Remarks |
Dec 22 '25 |
Sale |
34.56 |
324 |
11,196 |
144,680 |
| Leproust Emily M. | Chief Executive Officer |
Dec 22 '25 |
Sale |
34.56 |
1,605 |
55,462 |
874,313 |
1.12%
0.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):